R. Douglas Norby, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 20,000 shares at $40.28 ($806K) on 2009-06-19, disclosed to the SEC on 2009-06-19.
Scheduled sale ($806k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALXN | SELL | 2013-05-23 | $4.1M | — | Filing → |
| ALXN | SELL | 2012-12-12 | $2.0M | — | Filing → |
| ALXN | SELL | 2012-03-12 | $2.6M | — | Filing → |